What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
James O. Armitage mostly deals with Lymphoma, Internal medicine, Surgery, Pathology and Transplantation.
His Lymphoma study combines topics in areas such as Peripheral T-cell lymphoma, Survival analysis and Chemotherapy.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.
His work investigates the relationship between Oncology and topics such as Rituximab that intersect with problems in CHOP.
The study incorporates disciplines such as Bone marrow and Carmustine in addition to Transplantation.
His Diffuse large B-cell lymphoma study incorporates themes from Cancer research, Gene expression profiling, Germinal center, B cell and Aggressive lymphoma.
His most cited work include:
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (8095 citations)
- A predictive model for aggressive non-Hodgkin's lymphoma (3353 citations)
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas (3188 citations)
What are the main themes of his work throughout his whole career to date?
James O. Armitage focuses on Internal medicine, Lymphoma, Oncology, Surgery and Pathology.
He has included themes like Gastroenterology and Immunology in his Internal medicine study.
His Lymphoma study frequently draws connections between adjacent fields such as Disease.
His Oncology research is multidisciplinary, relying on both Combination chemotherapy, CHOP, Hodgkin lymphoma, Salvage therapy and Radiation therapy.
His research investigates the connection between Surgery and topics such as Bone marrow that intersect with problems in Haematopoiesis.
His Pathology study combines topics in areas such as Peripheral T-cell lymphoma, Immunophenotyping, Survival analysis and Cytogenetics.
He most often published in these fields:
- Internal medicine (50.15%)
- Lymphoma (43.22%)
- Oncology (28.91%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (50.15%)
- Oncology (28.91%)
- Lymphoma (43.22%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Lymphoma, Surgery and Pathology are his primary areas of study.
In his study, Multiple myeloma and Stem cell is inextricably linked to Transplantation, which falls within the broad field of Oncology.
Within one scientific family, James O. Armitage focuses on topics pertaining to Chemotherapy under Lymphoma, and may sometimes address concerns connected to Anthracycline.
His work on Overall survival as part of general Surgery research is frequently linked to Surveillance, Epidemiology, and End Results, bridging the gap between disciplines.
His work deals with themes such as Gastroenterology, Immunophenotyping and BCL6, which intersect with Pathology.
As part of one scientific family, James O. Armitage deals mainly with the area of Diffuse large B-cell lymphoma, narrowing it down to issues related to the Cancer research, and often B cell.
Between 2012 and 2021, his most popular works were:
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update (392 citations)
- Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project (187 citations)
- MYC and BCL2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab (128 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
James O. Armitage mainly focuses on Lymphoma, Internal medicine, Oncology, Pathology and Surgery.
His Lymphoma research incorporates themes from Survival analysis and Disease.
His work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Follicular lymphoma, Peripheral T-cell lymphoma and Serum lactate dehydrogenase level.
His Oncology research integrates issues from Myeloid, Regimen, Radiation therapy and Nuclear medicine.
His Blastoid study, which is part of a larger body of work in Pathology, is frequently linked to Statistical analysis, bridging the gap between disciplines.
James O. Armitage interconnects Brentuximab vedotin, Radiology, Cumulative incidence and Confidence interval in the investigation of issues within Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
